BET degrader exhibits lower antiproliferative activity than its inhibitor via EGR1 recruiting septins to promote E2F1-3 transcription in triple-negative breast cancer

Nan Liu(Hubei University of Medicine), Quan Liu(Jilin University), Nan Zhao(Army Medical University), Ying Zhao(Sinopec (China)), Shuai Wang(Lanzhou University), Deyu Wang(Jianghan University), Fangbin Han(GlaxoSmithKline (China)), Luoyi Zhao(Jilin University), Siwei Zhang(Jilin University), Munan Li(First Bethune Hospital of Jilin University), Rui Zhang(Shanghai University of Engineering Science), Mingxin Yu(Jilin University)
Pharmacological Research
August 28, 2024
Cited by 6


Related Papers